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AbstrACt 
Objective Many journals permit authors to submit 
supplementary material for publication alongside the 
article. We explore the value, use and role of this material 
in biomedical journal articles from the perspectives of 
authors, peer reviewers and readers.
Design and setting We conducted online surveys 
(November–December 2016) of corresponding authors and 
peer reviewers at 17 BMJ Publishing Group journals in a 
range of specialities.
Participants Participants were asked to respond to one of 
three surveys: as authors, peer reviewers or readers.
results We received 2872/20340 (14%) responses: 
authors 819/6892 (12%), peer reviewers 1142/6682 (17%) 
and readers 911/6766 (14%). Most authors submitted 
(711/819, 87%) and 80% (724/911) of readers reported 
reading supplementary material with their last article, 
while 95% (1086/1142) of reviewers reported seeing these 
materials sometimes. Additional data tables were the most 
common supplementary material reported (authors: 74%; 
reviewers: 89%; readers: 67%). A majority in each group 
indicated additional tables were most useful to readers 
(61%–77%); 20%–36% and 3%–4% indicated they 
were most useful to peer reviewers and journal editors, 
respectively. Checklists and reporting guidelines showed 
the opposite: higher proportions of each group regarded 
these as most useful to journal editors. All three groups 
favoured the publication of additional tables and figures 
on the journal’s website (80%–83%), with <4% of each 
group responding that these do not need to be available. 
Approximately one-fifth (16%–23%) responded that raw 
study data should be available on the journal’s website, 
while 24%–33% said that these materials should not be 
made available anywhere.
Conclusions Authors, peer reviewers and readers agree 
that supplementary materials are useful. Supplementary 
tables and figures were favoured over reporting checklists 
or raw data for reading but not for study replication. 
Journals should consider the roles, resource costs and 
strategic placement of supplementary materials to ensure 
optimal usage and minimise waste.
trial registration number NCT02961036. 
bACkgrOunD
Many journals allow or require authors to 
submit supplementary material along with 
their manuscript. These materials might 
help in deciding about the publication of 
the article (such as completed checklists 
for reporting guidelines) or provide addi-
tional information for readers who wish to 
delve deeper into the findings, replicate the 
research or use it for secondary analysis. The 
materials might also help improve access in 
the context of initiatives such as the Find-
ability, Accessibility, Interoperability and 
Reusability Data Principles for the automatic 
finding and use of scientific data,1 and the 
wish to facilitate automation in the systematic 
review process.2 
The volume of supplementary materials is 
accelerating in step with research complexity 
and multidisciplinary alliances. For example, 
Schriger et al show the percentage of articles 
containing supplementary materials increasing 
from 7% in 2003 to 25% in 2009 with web-only 
supplementary materials doubling in the same 
time period.3 Scientific journals report chal-
lenges in keeping up, citing reviewer fatigue, 
publishing delays, bloated publishing repos-
itories and confusion, as it is not unusual for 
articles that occupy 5–7 pages in the journal to 
present with over 140 pages of supplementary 
data or for systematic reviews or trial reports to 
include several hundred pages of information 
that would be needed to replicate, but not to 
report the findings of the research.4–7 Supple-
mentary materials might provide additional 
strengths and limitations of this study
 ► Our large sample from a diverse group of active 
international authors and reviewers from 17 differ-
ent journals provide evidence for stakeholder views 
on supplementary materials within the biomedical 
literature.
 ► The response rate is comparable to response rates 
for other electronic surveys of researchers.
 ► Participants were asked to respond in the as-
signed role/perspective of a reader, peer reviewer 
or author, although these are not mutually exclusive 
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results from a study or the detail needed to replicate the 
methods or present formulas, statistical models, interven-
tion details or algorithms. Some journals refuse the mate-
rials as excessive, while others allow ‘reasonable use’ which 
each journal defines individually.4–7 This is set within the 
backdrop of an increasing demand for research transpar-
ency through the sharing of all findings and corresponding 
data.8 Although standards for supplementary materials were 
suggested in 2012 by the National Information Standards 
Organisation and the National Federation of Advanced 
Information Services,9 the concerns of medical journals 
were not specifically considered and any policy adopted by 
medical journal editors will have implications for readers, 
editors, reviewers and the general public.
Clinicians and researchers struggle to keep up with 
reading the literature. Nearly a decade ago, Bastian et al 
reported the publication of 75 trials and 11 systematic 
reviews per day and asked ‘how will we ever keep up?’10 The 
numbers have continued to increase since then and the 
challenges have been compounded by the burgeoning 
supplementary material and problems with incompatible 
file systems, bandwidth restrictions and broken weblinks.11 
The increasing volume of supplementary materials 
submitted to journals puts more pressure on journal 
editors and peer reviewers to retrieve relevant informa-
tion from multiple sources.7 Schaffer and Jackson12 make 
recommendations on how access to supplementary mate-
rial can be improved. There is concern that the exces-
sive volume of supplementary materials can influence 
decisions made during peer review and skew the integ-
rity of the scientific record.6 A recent study of research 
manuscripts submitted to JAMA, JAMA Internal Medicine 
and JAMA Pediatrics found that manuscripts with supple-
ments were more likely to be peer reviewed and accepted 
than those without supplements.13 The requirements 
and practices of journals around supplementary mate-
rials vary12 14 and journals’ expectations of peer reviewers 
in terms of supplementary material are often not made 
clear in guidance to reviewers.6 For example, some jour-
nals explicitly state that supplementary material will not 
be peer reviewed, while others only mention that it will 
not be typeset. This variety of approaches forces authors, 
reviewers and readers to place different degrees of priori-
tisation and importance on supplementary material when 
including, reading or using them.
The use of supplementary materials during and after 
submission and publication is patchy, and the perceived 
value to stakeholders of the work involved in producing, 
assessing and using them is unclear.13 15 We conducted a 
survey to help resolve these uncertainties and to inves-
tigate the role of supplementary material in biomedical 
journal articles from the perspective of authors, peer 
reviewers and readers.
MethODs
This survey is registered at  ClinicalTrials. gov.
sampling
Journal sampling
Participants were drawn from a sample of 17 of BMJ 
Publishing Group’s biomedical journals (online supple-
mentary appendix 1). Journals varied in size and impact 
factor but each has a website and publishes supplemen-
tary material.
Participant sampling
One author (SS) downloaded contact details of all corre-
sponding authors who submitted a full-length original 
research submission to one of the 17 journals in 2013 
and all peer reviewers who had completed a review of a 
research submission for one of the journals in 2014 from 
the journal manuscript tracking systems. She used Micro-
soft Excel to remove duplicates from within each journal 
subsample and then across author/reviewer samples 
for all journals based on the person’s email address. We 
sent each sampled email address an invitation to just 
one of the three surveys, but it is possible some dupli-
cates remained if an individual had more than one email 
address in the manuscript tracking systems. We excluded 
potential participants if they had previously opted out of 
receiving BMJ communications or had participated in a 
BMJ research survey within the previous 6 months.
Two-thirds of the authors were randomly assigned to 
receive the Author Survey, two-thirds of the peer reviewers 
were randomly assigned to receive the Reviewer Survey 
and one-third of each sample was randomised to receive 
the Reader Survey, under the assumption that all partici-
pants were likely to be readers of journal articles.
Questionnaire administration
The surveys were developed by the researchers and 
piloted with 45 volunteers to check for ambiguous ques-
tions. The surveys were revised based on this feedback 
before launching.
Participants were sent an email invitation in November 
2016 to complete an online survey administered using 
SurveyMonkey. Non-respondents were sent up to two 
reminders. Participants were asked to complete the 
survey from the perspective of their allocated role to 
provide information about their use of specific types of 
supplementary material (study protocol, data collection 
or extraction forms, data tables and figures, completed 
reporting guideline checklists and flow diagrams, inter-
view transcripts and raw study data). Survey questions 
asked who the material is most useful to; the expected 
use of materials by authors, reviewers and readers; the 
preferred option for accessing supplementary mate-
rial and if and where supplementary material should 
be published. The questions and response categories 
for each of the survey instruments are shown in online 
supplementary appendices 2–4.
statistical analysis
Data were exported into Excel, cleaned and anonymised 
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SPSS V.22. Descriptive and summary statistics of interval 
scale variables were calculated using mean and stan-
dard deviation (or median and IQR for skewed data), 
and categorical data as frequency and percentages. Data 
have been reported from the individual perspectives of 
authors, readers and reviewers, as well as the aggregated 
overall perspective.
Public and patient involvement
Forty-five volunteers piloted the surveys and shared valu-
able feedback to make the questions clear and unam-
biguous. These volunteers were community members, 
physicians, researchers, patients and teachers.
results
Online supplementary appendix 5 shows which questions 
in the surveys pertain to our findings presented below 
and in the tables and appendices.
respondent characteristics
We sent the survey by email to 20 340 people and received 
2872 (14%) responses (819 (12%) from authors, 1142 
(17%) from peer reviewers and 911 (14%) from those 
responding as readers); see table 1. The numbers of years 
as an active researcher were comparable across respon-
dents with a mean of 4.4 years (SD 1.96) for authors, 4.6 
years (SD 1.98) for readers and 5.3 years (SD 2.89) for 
reviewers. The approximate number of research papers 
reported as published by respondents was a median of 46 
overall (36 for authors, 41 for readers, 51 for reviewers, 
which are statistically different across the groups: inde-
pendent samples Kruskal-Wallis test p<0.001) but with a 
spread of experience (IQR: 81 research papers). More 
than 87% of respondents read articles in medical jour-
nals either frequently or very frequently. Respondents are 
from an international sample, with authors from 65 coun-
tries, reviewers from 57 and readers from 53 countries.
respondent’s interaction with supplementary material
When recalling what supplementary material was 
contained in their last article submitted, authors stated 
including additional tables of data (74%) or additional 
figures (57%) most frequently, followed by checklists for 
relevant reporting guidelines (39%). Readers recalled 
reading additional tables of data (67%) or additional 
figures (53%), followed by study protocol (23%). Over 
80% of reviewers recalled the use of additional figures 
and tables of data in articles they peer reviewed some-
times or often, in contrast to more than 80% reporting 
rarely seeing raw study data or interview transcripts 
(online supplementary appendix 6).
Preferred option for accessing supplementary material
Overall (n=2872) respondents’ preferred option for 
accessing tables of data and additional figures was as 
supplementary files alongside the article (60% and 59%, 
respectively), while 50% chose this as their preferred 
option for data collection forms and completed check-
lists for relevant reporting guidelines. In contrast, 40% 
of respondents preferred that interview transcripts and 
raw study data would not be made available (see figure 1 
for overall data and online supplementary appendix 7 for 
responses by group).
The open-text responses to accessing supplementary 
materials also showed common sentiment across readers, 
reviewers and authors; as illustrated by this quote ‘It 
depends on the type of research and my purpose for accessing 
it. If I am only reading for enjoyment or for an overview of the 
topic I seldom look at supplementary materials but to replicate 
the research or to further verify the authors findings or methods, 
the supplementary materials provide nuances the paper does not.’
Who the material is most useful to
Figure 2 shows the overall views of who each type of 
supplementary material is most useful to, from the total 
of 2872 respondents. Additional tables of data and addi-
tional figures were deemed to be most useful to readers 
(>65%), while the study protocol and data collection/
extraction forms were deemed most useful to peer 
reviewers (>40%), in contrast to the completed check-
lists which were deemed most relevant to journal editors 
(40%).
Table 2 (and online supplementary appendix 8) 
further stratifies these opinions by allocated group, which 
Table 1 Characteristics of respondents
Authors Readers Reviewers Overall
Number (%) of sample 819 (28.5) 911 (31.7) 1142 (39.8) 2872 (100)
Mean (SD) number of years as an active researcher 4.4 (1.96) 4.6 (1.98) 5.3 (2.89) 4.8 (2.41)
Approximate number of research papers published as 
author or coauthor—median (IQR)
36 (68.5) 41 (75) 51 (77) 46 (81)
Number (%) on how frequently they read articles in medical journals 
  Very frequently 377 (46.0) 462 (54.2) 628 (55.0) 1467 (51.1) 
  Frequently 337 (41.1) 331 (38.8) 383 (33.5) 1051 (36.6) 
  Occasionally 58 (7.1) 58 (6.4) 55 (4.8) 171 (6.0) 
  Rarely 3 (0.4) 1 (0.1) 7 (0.6) 11 (0.4) 
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reveals similar trends to those given overall. For instance, 
additional tables of data were regarded as most useful to 
readers (58%–72%) by all groups (authors, reviewers and 
readers), while checklists were perceived as more useful 
to journal editors or peer reviewers rather than readers 
(36%–45% versus 12%–16%).
If and where supplementary material should be published
Figure 3 depicts the overall views on where (each type 
of) supplementary material should be published, be this 
on the website alongside the article, on another website, 
available directly from the authors, or that it does not 
need to be available. The responses are not mutually 
exclusive, but more than 81% preferred to see additional 
tables of data and figures on a website along with the 
article. In contrast, respondents preferred interview tran-
scripts (37%) and raw study data (39%) to be available 
by contacting the article’s corresponding author, with a 
further 30% and 27% respondents indicating these mate-
rials did not need to be made available, respectively. Other 
forms of supplementary material, for example, checklists, 
were perceived variably with responses of either availability 
on the website along with the article (45%) or of no need 
to be available (23%). Online supplementary appendix 9 
shows that the responses were similar by group. 
In the open-text responses, there were multiple requests 
for inclusion and publication of replicable software codes, 
dynamic models with the modelling results, statistical 
models, videos and models for imaging and genetics while 
others saw no need for supplementary materials stating 
that the responsibility of the authors was to deliver clear 
and concise reporting that would fit within the given word 
limits of a paper. An important consideration noted by 
some respondents was that some data were restricted and 
could not be shared without compromising the identities 
of participants particularly in data linkage sets. Respon-
dents stressed the need for improved navigation both of 
the website to access the materials and of the materials 
themselves in terms of labelling, ordering and readability. 
Figure 1 Overall views of preferred option for providing/reading/receiving supplementary material (n=2872).
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It was suggested that supplementary materials for an article 
should be downloadable as a single zipped file.
expected use of materials by authors, reviewers and readers
Almost half the authors who responded expect that peer 
reviewers should routinely read all supplementary mate-
rial. But on asking reviewers what they do with supple-
mentary material, 8%–16% ignored completed checklists, 
flow diagrams, interview transcripts and raw study data, 
with 11%–26% saying it depended on the manuscript. We 
found that only additional tables of data and additional 
figures were being routinely read entirely, at approximately 
60%, with other categories below 36%. In response to the 
question about what they usually do with supplementary 
materials, no more than 27% of readers responded that they 
routinely read all of any type of supplementary material, with 
30%–40% ignoring completed checklists, flow diagrams, 
interview transcripts and raw study data (see online supple-
mentary appendix 10–12).
DIsCussIOn
In general, authors, reviewers and readers expressed a 
preference for supplementary material that provided 
additional tables over completed reporting checklists or 
Table 2 Author, reviewer and reader perspectives on the value of additional tables of data, completed checklists for reporting 
guidelines and raw study data by group*†
Group
No/total no (%) most useful to
To journal editors To peer reviewers To readers
Additional tables of data
  Authors 29/819 (4) 187/819 (23) 564/819 (69)
  Reviewers 32/1142 (3) 384/1142 (34) 662/1142 (58)
  Readers 25/911 (3) 172/911 (19) 659/911 (72)
  Overall 68/2872 (3) 743/2872 (26) 1885/2872 (66)
Completed checklists for reporting guidelines
  Authors 365/819 (45) 291/819 (36) 96/819 (12)
  Reviewers 453/1142 (40) 414/1142 (36) 186/1142 (16)
  Readers 340/911 (37) 394/911 (43) 117/911 (13)
  Overall 1158/2872 (40) 1099/2872 (38) 399/2872 (14)
Raw study data
  Authors 120/819 (15) 309/819 (38) 276/819 (34)
  Reviewers 207/1142 (18) 767/1142 (35) 385/1142 (34)
  Readers 119/911 (13) 387/911 (42) 283/911 (31)
  Overall 446/2872 (16) 1093/2872 (38) 944/2872 (33)
*Percentages do not sum to 100% across each row because some respondents did not answer every question.
†A table showing the responses for all types of supplementary material is given in our online supplementary material.
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raw data when reading research articles. This may high-
light a greater desire among these users of research to 
have access to information that has been analysed or 
summarised by the original researchers. A recurring 
theme in free-text comments was how the importance 
and value of supplementary materials depended on the 
purpose for which they were accessed. For example, 
respondents noted that as interested readers they might 
not access any supplementary materials but that they 
would want to be able to access supplementary materials 
for analysis, replication, secondary research or teaching 
purposes. The respondents also expressed concerns 
about data accessibility, security and the persistence of all 
data, as well as concerns about protecting the trustworthi-
ness and viability of permissions for raw data (particularly 
when made available to third parties). Considering these 
findings, our survey adds impetus to calls to improve the 
quality of reporting, the use of reporting guidelines15–17 
and the evaluation of the impact of initiatives intended to 
improve the quality of the literature and decisions based 
on it. The survey also revealed uncertainty about the use 
and placement of supplementary materials, as illustrated 
by the following representative open-text comment:
A manuscript to be published should be able to stand 
on its own. Journals are making a mistake by making 
article word counts shorter, then having supplemen-
tary material. If more data are needed to understand 
the study, they should be in the article
In 2009–2011, the journals Cell, The Journal of Neuro-
science and Science announced that they would not allow 
authors to include supplemental material on submission 
or host supplemental material on their websites. Instead, 
authors were given the option of including a URL to 
direct readers to the supplementary material on a website 
maintained by the authors, along with a short descrip-
tion of the supplementary material.4 5 18 However, we 
found little support from our respondents for including 
a weblink within the published paper or for requesting 
supplementary material directly from investigators by 
email. Although journals and researchers may feel a social 
responsibility to make data publicly and permanently avail-
able,18 they often lack the necessary tools or collaborators 
to build and maintain persistent repositories. Private web 
pages and email are not persistent over time and may be 
vulnerable to corruption. Hofner and colleagues recom-
mend the use of recognised repositories where digital 
object identifiers are supplied as good practice for data 
preservation and to preserve the options to replicate 
the findings.19 There is considerable debate over how to 
make research more transparent and reproducible.20 As 
supplementary material often contains content that helps 
make research more reproducible, it is important for it to 
be accessible in the long term to help improve research 
efficiency. Others argue that the supplementary material 
needs to be better structured to avoid computational 
errors and to enable machine reading, particularly in the 
fields of genomics, neuroscience, chemistry and other 
basic sciences.21 Pop and Salzberg proposed that specific 
sections of the supplementary material should be directly 
hyperlinked within the text of the article to improve the 
utility of published scientific articles and to increase the 
likelihood that this material is adequately peer reviewed.6
study limitations
Our response rate of 14% is typical of current response 
rates for electronic surveys to researchers,22 but still 
allowed us to achieve a large sample, with nearly 3000 
responses from a diverse group of international authors 
and reviewers from 17 biomedical journals. As such, our 
findings make a substantial contribution to the evidence 
on stakeholder views on the value of supplementary 
materials within the peer-reviewed biomedical literature. 
Participants were asked to respond in the assigned role/
perspective of a reader, peer reviewer or author, and these 
are not mutually exclusive categories, as academics often 
engage in all three activities. Participants gave general 
perceptions and were not asked to report on specific 
cases or the purpose of accessing the article and this may 
have influenced responses.
remaining uncertainties and future research
Some respondents expressed a preference in open-text 
comments for standardised, well-organised supplemen-
tary materials that could be combined into a single 
zipped file for downloading or offered as a persistent 
link. However, others commented that data protection 
standards and ethical oversight might not be explicitly 
extended to making supplementary materials publicly 
available. These concerns were not directly addressed 
within the survey questions and so it is not known how 
representative or widespread these opinions might be. 
However, the views expressed could be the target of 
further investigation. It may also be worth investigating 
the relationship between the value of supplementary 
material and the cost of production and publication to 
researchers should journals take on the responsibility for 
the state of supplementary materials in terms of perpetual 
availability, typesetting and compatibility.
COnClusIOns
Our findings provide evidence that should help jour-
nals, researchers and funders to consider the roles, costs 
and benefits of supplementary materials. The findings 
highlight, for example, a greater desire among users of 
research to have access to information that has already 
been analysed or summarised by the original researchers, 
rather than their raw material. It may be helpful for jour-
nals to expand file types to allow storage of, and access 
to a variety of file types, including multimedia, computer 
models and working software prototypes. Our survey 
should also add impetus to calls to improve the quality of 
reporting and the use of reporting guidelines,15–17 and we 
hope that it will stimulate greater emphasis on the need 
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improve the quality of health research and the decisions 
that will subsequently be based on this literature.
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